Deeply reinverted T wave at 14 days after the onset of first anterior acute myocardial infarction predicts improved left ventricular function at 6 months. 2015

Hiroaki Yokoyama, and Hirofumi Tomita, and Fumie Nishizaki, and Kenji Hanada, and Shuji Shibutani, and Masahiro Yamada, and Naoki Abe, and Takumi Higuma, and Tomohiro Osanai, and Ken Okumura
Department of Cardiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

BACKGROUND Changes in electrocardiogram (ECG), especially in the ST segment and T wave, have been recognized as a noninvasive diagnostic tool for coronary flow or myocardial injury. OBJECTIVE A deeply inverted T wave at 14 days after successful percutaneous coronary intervention (PCI) in patients with ST-segment elevation acute myocardial infarction (STEMI) predicts improved left ventricular (LV) function at 6 months. METHODS We enrolled 112 consecutive patients (88 men, 63 ± 11 years) with first anterior STEMI who underwent successful PCI. A 12-lead ECG was recorded everyday from admission through 14 days. After PCI, the first T-wave inversion was observed within 2 days, and the second occurred at 14 days. We measured the maximum depth of the reinverted T wave (Neg-T) and divided the patients into 2 groups based on the median value of Neg-T: the deep group (≥0.6 mV, n = 62) and the nondeep group (<0.6 mV, n = 50). RESULTS LV ejection fraction (LVEF) at 14 days did not differ between the 2 groups, but it was greater in the deep than in the nondeep group at 6 months (50.0% ± 8.8% vs 42.5% ± 9.8 %, P < 0.0001). The maximum creatinine phosphokinase-myocardial band (CPK-MB) value was significantly lower in the deep than in the nondeep group. Reappearance of the R wave in precordial leads at 6 months was more frequently observed in the deep than in the nondeep group (68% vs 46%, P = 0.02). Multivariate regression analysis showed that the Neg-T and max CPK-MB were independent contributors to LVEF at 6 months. CONCLUSIONS A deeply reinverted T wave at 14 days after onset of first anterior STEMI can be a useful predictive marker for improved LV function at 6 months.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013318 Stroke Volume The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume. Ventricular Ejection Fraction,Ventricular End-Diastolic Volume,Ventricular End-Systolic Volume,Ejection Fraction, Ventricular,Ejection Fractions, Ventricular,End-Diastolic Volume, Ventricular,End-Diastolic Volumes, Ventricular,End-Systolic Volume, Ventricular,End-Systolic Volumes, Ventricular,Fraction, Ventricular Ejection,Fractions, Ventricular Ejection,Stroke Volumes,Ventricular Ejection Fractions,Ventricular End Diastolic Volume,Ventricular End Systolic Volume,Ventricular End-Diastolic Volumes,Ventricular End-Systolic Volumes,Volume, Stroke,Volume, Ventricular End-Diastolic,Volume, Ventricular End-Systolic,Volumes, Stroke,Volumes, Ventricular End-Diastolic,Volumes, Ventricular End-Systolic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Hiroaki Yokoyama, and Hirofumi Tomita, and Fumie Nishizaki, and Kenji Hanada, and Shuji Shibutani, and Masahiro Yamada, and Naoki Abe, and Takumi Higuma, and Tomohiro Osanai, and Ken Okumura
October 1987, European heart journal,
Hiroaki Yokoyama, and Hirofumi Tomita, and Fumie Nishizaki, and Kenji Hanada, and Shuji Shibutani, and Masahiro Yamada, and Naoki Abe, and Takumi Higuma, and Tomohiro Osanai, and Ken Okumura
March 1996, Heart (British Cardiac Society),
Hiroaki Yokoyama, and Hirofumi Tomita, and Fumie Nishizaki, and Kenji Hanada, and Shuji Shibutani, and Masahiro Yamada, and Naoki Abe, and Takumi Higuma, and Tomohiro Osanai, and Ken Okumura
October 2002, Journal of the American College of Cardiology,
Hiroaki Yokoyama, and Hirofumi Tomita, and Fumie Nishizaki, and Kenji Hanada, and Shuji Shibutani, and Masahiro Yamada, and Naoki Abe, and Takumi Higuma, and Tomohiro Osanai, and Ken Okumura
January 2009, Cardiology,
Hiroaki Yokoyama, and Hirofumi Tomita, and Fumie Nishizaki, and Kenji Hanada, and Shuji Shibutani, and Masahiro Yamada, and Naoki Abe, and Takumi Higuma, and Tomohiro Osanai, and Ken Okumura
July 1988, The American journal of cardiology,
Hiroaki Yokoyama, and Hirofumi Tomita, and Fumie Nishizaki, and Kenji Hanada, and Shuji Shibutani, and Masahiro Yamada, and Naoki Abe, and Takumi Higuma, and Tomohiro Osanai, and Ken Okumura
January 1976, European journal of intensive care medicine,
Hiroaki Yokoyama, and Hirofumi Tomita, and Fumie Nishizaki, and Kenji Hanada, and Shuji Shibutani, and Masahiro Yamada, and Naoki Abe, and Takumi Higuma, and Tomohiro Osanai, and Ken Okumura
February 1989, The American journal of cardiology,
Hiroaki Yokoyama, and Hirofumi Tomita, and Fumie Nishizaki, and Kenji Hanada, and Shuji Shibutani, and Masahiro Yamada, and Naoki Abe, and Takumi Higuma, and Tomohiro Osanai, and Ken Okumura
February 2010, The American journal of cardiology,
Hiroaki Yokoyama, and Hirofumi Tomita, and Fumie Nishizaki, and Kenji Hanada, and Shuji Shibutani, and Masahiro Yamada, and Naoki Abe, and Takumi Higuma, and Tomohiro Osanai, and Ken Okumura
October 1989, Diabetes care,
Hiroaki Yokoyama, and Hirofumi Tomita, and Fumie Nishizaki, and Kenji Hanada, and Shuji Shibutani, and Masahiro Yamada, and Naoki Abe, and Takumi Higuma, and Tomohiro Osanai, and Ken Okumura
October 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography,
Copied contents to your clipboard!